Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 26, 2018 - Issue 7
Submit an article Journal homepage
228
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Vogt–Koyanagi–Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia

Carol L. GuayacánFundación Oftalmológica Nacional (FUNDONAL), Uveitis Service, Bogotá, Columbia
, MD,
Brahyan Galindo-MendezEscuela de Medicina y Ciencias de la Salud, Grupo de Investigación en Neurociencias (NeURos), Bogotá, Columbia
, MD &
Alejandra de-la-TorreFundación Oftalmológica Nacional (FUNDONAL), Uveitis Service, Bogotá, Columbia;Escuela de Medicina y Ciencias de la Salud, Grupo de Investigación en Neurociencias (NeURos), Bogotá, ColumbiaCorrespondence[email protected]
, MD, PhD
Pages 1123-1127 | Received 08 Dec 2016, Accepted 08 Jun 2017, Published online: 14 Sep 2017

References

  • Moorthy RS, Inomata HRN. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995 Jan-Feb;39(4):265–292.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.
  • Xu M, Wang C, Tian Y, et al. Inhibition of proinflammatory cytokine by IL-25 in Vogt–Koyanagi–Harada syndrome. Ocul Immunol Inflamm [Internet]. Informa Clin Med. 2013 Dec 11;22(4):294–299. doi:10.3109/09273948.2013.854391.
  • Herbort CP, Mochizuki M. Vogt–Koyanagi–Harada disease: Inquiry into the genesis of a disease name in the historical context of Switzerland and Japan. Int Ophthalmol. 2007;27(2–3):67–79.
  • De-Domingo B, Blanco MJ, Rodríguez-Cid MJ, et al. Vogt–Koyanagi–Harada syndrome. Arch Soc Esp Oftalmol. 2008 Jun;83(6):385–390.
  • Sukavatcharin S, Tsai JH, Rao NA. Vogt–Koyanagi–Harada disease in Hispanic patients. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):143–148. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17380271
  • Cardoso IZM. Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt–Koyanagi–Harada disease patients. Arq Bras Oftalmol. 2008;71(1):67–70.
  • De-La-Torre A, López-Castillo CA, Rueda JC, et al. Clinical patterns of uveitis in two ophthalmology centres in Bogotá, Colombia. Clin Experiment Ophthalmol. 2009 Jul;37(5):458–466.
  • Pan D, Hirose T. Vogt–Koyanagi–Harada syndrome: Review of clinical features. Semin Ophthalmol. 2011;26(4–5):312–315.
  • Da Silva FTBGC, Damico FM, Marin ML, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: Considerations on the different disease categories. Am J Ophthalmol [Internet]. Elsevier Inc. 2009 Feb [cited 2014 Feb 1]; 147(2):339–345.e5. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18992868
  • Fang W, Yang P. Vogt–Koyanagi–Harada syndrome. Curr Eye Res. 2008 Jul;33(7):517–523.
  • Chee S-P, Jap A, Bacsal K. Prognostic factors of Vogt–Koyanagi–Harada disease in Singapore. Am J Ophthalmol. 2009 Jan;147(1):154–161.e1.
  • Bordaberry MF. Vogt–Koyanagi–Harada disease: Diagnosis and treatments update. Curr Opin Ophthalmol. 2010 Nov;21(6):430–435.
  • Soheilian M, Aletaha M, Yazdani S, et al. Management of pediatric Vogt–Koyanagi–Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm. 2006 Apr;14(2):91–98.
  • Kiyomoto C, Imaizumi M, Kimoto K, et al. Vogt–Koyanagi–Harada disease in elderly Japanese patients. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):149–153. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17437061
  • Tugal-Tutkun I, Ozyazgan Y, Akova YA, et al. The spectrum of Vogt–Koyanagi–Harada disease in Turkey: VKH in Turkey. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1]; 27(2–3):117–123. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16957877
  • Rao NA, Sukavatcharin S, Tsai JH. Vogt–Koyanagi–Harada disease diagnostic criteria. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):195–199. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17384920
  • Abad S, Monnet D, Caillat-Zucman S, et al. Characteristics of Vogt–Koyanagi–Harada disease in a French cohort: Ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm [Internet]. 2008 [cited 2014 Feb 1]; 16(1):3–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18379934
  • Murthy SI, Moreker MR, Sangwan VS, et al. The spectrum of Vogt–Koyanagi–Harada disease in South India. Int Ophthalmol [Internet]. 2007 [cited 2014 Feb 1];27(2–3):131–136. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17318321
  • Abu El-Asrar AM, Al Tamimi M, Hemachandran S, et al. Prognostic factors for clinical outcomes in patients with Vogt–Koyanagi–Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91(6):486–493.
  • Sakata VM, Silva FT, Hirata CE, Marin ML, Rodrigues H, Kalil J, Costa RA, Yamamoto JH. High rate of clinical recurrence in patients with Vogt–Koyanagi–Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol. 2015; 253(5):785–790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.